OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic targeting of regulatory T cells in cancer
Feng Shan, Ashwin Somasundaram, Tullia C. Bruno, et al.
Trends in cancer (2022) Vol. 8, Iss. 11, pp. 944-961
Open Access | Times Cited: 107

Showing 1-25 of 107 citing articles:

T cells in health and disease
Lina Sun, Yanhong Su, Anjun Jiao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 321

Regulatory cells and the effect of cancer immunotherapy
María Iglesias-Escudero, Noelia Arias-González, Eva Martı́nez-Cáceres
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 103

Nanozyme-mediated biocatalysis as a mitochondrial oxidative stress amplifier for tumor nanocatalytic immunotherapy
Junya Lu, Luming Song, Shuaipeng Feng, et al.
Chemical Engineering Journal (2023) Vol. 481, pp. 148270-148270
Closed Access | Times Cited: 71

Modulating Treg stability to improve cancer immunotherapy
Jee Hye Kang, Roberta Zappasodi
Trends in cancer (2023) Vol. 9, Iss. 11, pp. 911-927
Open Access | Times Cited: 53

Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escape
Jiawen Cui, Yao Li, Yang Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116203-116203
Open Access | Times Cited: 30

Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 21

Large scale plasma proteomics identifies novel proteins and protein networks associated with heart failure development
Amil M. Shah, Peder L. Myhre, Victoria Arthur, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 17

Interactions and communications in lung tumor microenvironment: Chemo/radiotherapy resistance mechanisms and therapeutic targets
Feng Yuan, Ying Jiang, Lin Yang, et al.
Journal of drug targeting (2025), pp. 1-33
Closed Access | Times Cited: 1

The antitumor activities of anti-CD47 antibodies require Fc-FcγR interactions
Juan C. Osorio, Patrick Smith, David A. Knorr, et al.
Cancer Cell (2023) Vol. 41, Iss. 12, pp. 2051-2065.e6
Open Access | Times Cited: 30

Antibody-based cancer immunotherapy by targeting regulatory T cells
Quanxiao Li, Jun Lu, Jinyao Li, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 22

Sodium chloride in the tumor microenvironment enhances T cell metabolic fitness and cytotoxicity
Dominik Soll, Chang-Feng Chu, Shan Sun, et al.
Nature Immunology (2024) Vol. 25, Iss. 10, pp. 1830-1844
Open Access | Times Cited: 11

Lactate acid promotes PD-1+ Tregs accumulation in the bone marrow with high tumor burden of Acute myeloid leukemia
Yining Zhang, Yueting Huang, Hong Yan, et al.
International Immunopharmacology (2024) Vol. 130, pp. 111765-111765
Closed Access | Times Cited: 8

Human iPSC-derived CD4+ Treg-like cells engineered with chimeric antigen receptors control GvHD in a xenograft model
Hisashi Yano, Keiko Koga, Takayuki Sato, et al.
Cell stem cell (2024) Vol. 31, Iss. 6, pp. 795-802.e6
Open Access | Times Cited: 8

Systemic and local immunosuppression in glioblastoma and its prognostic significance
Aleksei A. Stepanenko, Anastasiia O. Sosnovtseva, M. P. Valikhov, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7

Targeting the metabolism of tumor-infiltrating regulatory T cells
Yiming Wang, Tianning Huang, Jian Gu, et al.
Trends in Immunology (2023) Vol. 44, Iss. 8, pp. 598-612
Open Access | Times Cited: 19

Learning from the nexus of autoimmunity and cancer
Davide Mangani, Dandan Yang, Ana C. Anderson
Immunity (2023) Vol. 56, Iss. 2, pp. 256-271
Open Access | Times Cited: 17

Effect of infiltrating immune cells in tumor microenvironment on metastasis of hepatocellular carcinoma
Yiwen Chen, Yuhang Zhou, Ziyang Yan, et al.
Cellular Oncology (2023) Vol. 46, Iss. 6, pp. 1595-1604
Closed Access | Times Cited: 17

The multifaceted roles of GSDME-mediated pyroptosis in cancer: therapeutic strategies and persisting obstacles
Yixiang Hu, Ya Liu, Lijuan Zong, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 16

Metabolic interplay: tumor macrophages and regulatory T cells
Stefania Vilbois, Yingxi Xu, Ping‐Chih Ho
Trends in cancer (2023) Vol. 10, Iss. 3, pp. 242-255
Closed Access | Times Cited: 16

Integrated BATF transcriptional network regulates suppressive intratumoral regulatory T cells
Feng Shan, Anthony R. Cillo, Carly Cardello, et al.
Science Immunology (2023) Vol. 8, Iss. 87
Open Access | Times Cited: 15

Intersecting Paths: Unraveling the Complex Journey of Cancer to Bone Metastasis
Nour Arakil, Shahid Akhtar Akhund, Basant Elaasser, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1075-1075
Open Access | Times Cited: 6

Unraveling the tumor microenvironment of esophageal squamous cell carcinoma through single-cell sequencing: A comprehensive review
Lingyu Qi, Jiaxin Wang, Shuang Hou, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189264-189264
Closed Access

CD4 + FOXP3Exon2 + regulatory T cell frequency predicts breast cancer prognosis and survival
Clorinda Fusco, Francesca Di Rella, Antonietta Liotti, et al.
Science Advances (2025) Vol. 11, Iss. 3
Closed Access

Page 1 - Next Page

Scroll to top